Editor's Blog
The Top Five Boardroom Issues Compliance Officers Should Be Discussing
GUEST BLOG POST Lately, I've been reflecting on my experience presenting compliance updates to boards, both during my industry days...
Research Digest
SEC Sets Record Year in Enforcement with $8.2 Billion in Fines
T he Securities and Exchange Commission announced that it filed 583 total enforcement actions in fiscal year 2024, while obtaining...
Insight 360°
Managing Compliance in a Remote Work Environment
W e all know about the great migration to "work from home" that occurred during COVID-19 pandemic starting in 2020...
Featured news
CFPB Sues Major Banks and Zelle Operator for Alleged Fraud
The Consumer Financial Protection Bureau announced that it has sued Bank of America, JPMorgan, Wells Fargo, and the operator of Zelle, Early Warning Services, for failing to protect consumers from widespread fraud. Zelle is America’s most widely available payment network. According to the lawsuit, customers of the three banks have
Jacob Horowitz
December 20, 2024
0
Court Invalidates Nasdaq Board Diversity Requirements
A U.S. Court of Appeals court ruled that Nasdaq can no longer enforce its board diversity rules, vacating the Securities and Exchange Commission’s approval of a rule that requires disclosure of each board member’s racial, gender, and LGBTQ+ identification. The court found that the SEC went beyond the scope of
FTC Finalizes Rule that Aims to End Hidden ‘Junk Fees’
The Federal Trade Commission announced that it has finalized a Junk Fees Rule which essentially prohibits businesses in the live-event ticketing and short-term lodging industries from using bait-and-switch pricing and other tactics used to hide total prices and bury “junk fees.” The rule will ensure that pricing information is provided
McKinsey To Pay $650 Million to DoJ for Advising Client in Criminal Conduct
G lobal consulting firm McKinsey & Co. has agreed to pay $650 million to settle a Department of Justice investigation into the firm’s consulting work with opioids manufacturer Purdue Pharma. The DoJ had accused McKinsey of fueling the opioid epidemic with its aggressive sales and marketing advice to Purdue, including
